Redefining medicine through cannabinoid innovation.
Helping restore quality of life for patients suffering from chronic health conditions, and helping mitigate harmful opioid dependencies that have plagued society for decades.
Discovery
Our R&D Lab
GMP has and continues to invest heavily in research
and development. Our R&D Lab is the culmination
of countless hours of investigation and design
thinking to ensure we acheived a state-of-the-art lab
for our technicians and chemists.
GMP Headquarters
Our GMP headquarters over 100,000 sqf and built for Good Agricultural and Collecting Practices (GACP) cultivation and Good Manufacturing Processes (GMP) licences. Its equipped with solar panels throughout the entire roof and has a complete water recycling irrigation system.
Our Facility
Clinic & Offices
R&D
Bulk API Production
GMP Processing
Our People
Executive Team
Jonathan
Tick
Chief Executive Officer
Jonathan
Kronenfeld
President
Les
Kirsh
Cheif Financial Officer
Dr. Diego
Delgado, MD
Chief Medical Officer
Joel
Jacobs
International Relations
Technical Team
Dr. Rijul
Puri, MD
Director of Medical Affairs
Leo
Sivak
Master Grower
Dr. Sudhanshu
Sharma
Director of Quality & QAP
Alexander
Dementev, MSc
Product Scientist
Tal
Agarunov
Operations Manager
Rare & Common Cannabinoid Research
GMP has and continues to invest heavily in research
and development. Our R&D Lab is the culmination
of countless hours of investigation and design
o At GMP, we work tirelessly to produce both rare and
common cannabinoids. Thus far we have been able to
achieve amazing and ground breaking results with the
semi-synthetic production of common cannabinoids
such as ∆8 THC, ∆9 THC, CBD, and CBN. We also
have favarouble results and certificates of
analysis that conclude the successful production of
THCv, THCp, CBG, CBGa, CBDa, and CBDv. for our
technicians and chemists.
